1Raghu G,Weycker D,Edelsberg J,et al.Incidence and prevalence of idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2006,174(7):810–816.
2Turner-Warwich M,Lebowitz M,Burrows B,et al.Crytogenic fibro-sing alveolitis and lung cancer[J].Thorax,1980,35(7):496-499.
3Kawasaki H,Ogura T,Yokose T,et al.P53 gene alternation in atypical epithelial lesions and carcinoma in patients with idio-pathic pulm-onary fibrosis[J].Hum Pathol,2001,32(10):1043.
4Uematsu K,Yoshimura A,Gemma A,et al.Aberrations in the fragile histidine trial (FHIT) gene in idiopathic pulmonary fibrosis[J].Cancer Res,2001,61(23):8527-8533.
5Tsuboi M,Lechevalier T.Interstitial lung disease in patients with non-amall-cell lung cancer treated with epidermal growth factorreceptor inhibitors[J].Med oncol,2006,23(1):161-170.
6J.Park,D.S.Kim,T.S.Shim,et al.Lung cancer in patients with idio-pathic pulmonary fibrosis[J].Eur Respir J,2001,17(6):1216–1219.
7Noth I,FCCP,Fernando J,et al.Recent Advances in Idiopathic Pul-monary Fibrosis[J].Chest,2007,132(2):637-650.
